20 results
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... #AcutePE #Management ... #CriticalCare
Azithromycin - since there has been a lot of noise around chloroquine/hydroxychloroquine, thought we can take
for COVID-19… ... azithromycin has a long ... for potential DIs ... QT prolongation risk ... #Management #Pharmacology
In ARDS, we know that the lungs are so diffusely injured that the remaining total area
In ARDS, we know ... 3-4 ml/kg, the risk ... to minimize the risk ... #foamed #criticalcare ... #treatment #respiratory
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Chronic Obstructive Pulmonary ... chronic obstructive pulmonary ... and exacerbation risk ... of expiration; ICS ... #Pharmacology
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
Consolidations on Lung ... POCUS LUS for ICU ... Spare the risk to ... #clinical #lung ... #ultrasound #pulmonary
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
transfused patientsl • Risk ... : 33% • Treatment ... transfused patients • Risk ... At least 3 of (Acute ... , and CXR with pulmonary
Stress Ulcer Prophylaxis

Stress ulcerations are common in ICU patients and may lead to hemorrhage if not
are common in ICU ... ulceration or treatment ... Pathophysiology • Risk ... #Prophylaxis #criticalcare ... #pharmacology #
Noninvasive Positive Pressure Ventilation (NIPPV)

Expiratory & Inspiratory Positive Airway Pressure
Both increase intrathoracic pressure, which can decrease
in obstructive lung ... Post-extubation in high risk ... Contraindications: • Risk ... facial hair) • Risk ... #indications #criticalcare
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Trypanosomiasis) in HIV-AIDS ... with epidemic risk ... patients are still at risk ... patients with acute ... infections #HIVAIDS #pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Triggers: ATRA treatment ... Attempt if high risk ... Imaging: CXR- pulmonary ... Renal Failure Treatment ... organ dysfuxtion, ICU